Anita Kelsey, MD
Cardiovascular Disease · Hartford, CTNPI 1083617161
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,000 of the $7,642 with a category attached, or 65.4%. Lantheus Medical Imaging, Inc. accounts for 76.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $3,636 and has fallen 91.3% since, to $315 in 2025.
Across 28 payments — averaging $272.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$6K
- Abbott$2K
- Edwards Lifesciences$104
What the payments were for
- Speaking & faculty fees$5,00065%
- Travel & lodging$1,90625%
- Food & beverage$73510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 12 | $5,863 |
| Abbott | 15 | $1,675 |
| Edwards Lifesciences | 1 | $104 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,642 in reported general payments places this provider in the 80th percentile of 415 cardiovascular disease providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $27,152 |
| Metoprolol Succinate | 54 | $643 |
| Atorvastatin Calcium | 36 | $608 |
| Ezetimibe | 28 | $581 |
| Rosuvastatin Calcium | 32 | $519 |
| Amlodipine Besylate | 38 | $273 |
| Losartan Potassium | 40 | $224 |
| Lisinopril | 23 | $201 |
| Carvedilol | 27 | $163 |
| Nitroglycerin | 18 | $161 |
| Pravastatin Sodium | 11 | $139 |
| Furosemide | 19 | $115 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Hartford
- Stephanie SaucierHartford$243K
- Antonio FernandezHartford$113K
- Paul ThompsonHartford$108K
- Richard SoucierHartford$97K
- Atique MirzaHartford$29K
- Sean McMahonHartford$23K
- Lonny ReismanHartford$22K
- David HenryHartford$13K
- Nihar DesaiNew Haven$1.4M
- Brett NowlanBloomfield$798K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.